Apollo Hospitals Enterprise Limited vs Fresenius Kabi Oncology Ltd

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Fresenius Kabi Oncology Ltd (FKONCO) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Apollo Hospitals Enterprise Limited leads APOLLOHOSP vs FKONCO on 10 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability40
  • Growth10
  • Size & financial health31

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
0.00
13.46
P/B ratio
0.00
0.22%
Dividend yield
0.00%
₹135.04
EPS
₹-3.41

Profitability

APOLLOHOSP takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
11.20%
17.31%
Return on capital
9.00%
14.94%
EBITDA margin
14.00%
7.94%
Net margin
-8.18%

Growth

APOLLOHOSP takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
6.79%
33.35%
Profit CAGR (3Y) even
—

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹0 Cr
₹25,229 Cr
Revenue
₹660 Cr
₹2,003 Cr
Net profit
₹-54 Cr
0.90
Debt / equity
0.00
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.1% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.98 times its book value"]
Fresenius Kabi Oncology Ltd
  • − ["Stock is trading at 5.15 times its book value", "The company has delivered a poor sales growth of 10.1% over past five years.", "Tax rate seems low", "Company has a low return on equity of 6.57% over last 3 years.", "Company might be capitalizing the interest cost"]
Apollo Hospitals Enterprise Limited full analysis Fresenius Kabi Oncology Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.